Home Drugs Apixaban
Registry trials: Apixaban 22 registry trials linked to Apixaban with phase phase 3, of 46, newest start first. Assembled by a program from ClinicalTrials.gov. No person wrote or checked these pages, and they are counted apart from the pages that people wrote. Lists of trials come from the registry's own coding and may miss trials.
Each filter is a page of its own, so they work one at a time. Choose Whole list to start again.
Phase 3 Not yet recruiting Planned start 2026-11 848 planned NCT07779746
Phase 3 Recruiting Started 2026-10-15 460 planned NCT07471139
Phase 3 Recruiting Started 2026-08-26 1,600 planned NCT07493304
Phase 3 Recruiting Started 2026-08-10 15,364 planned NCT07626411
Phase 3 Recruiting Planned start 2026-06-22 218 planned NCT07709780
Phase 3 Not yet recruiting Planned start 2026-02 120 planned NCT07434661
Phase 3 Active, not recruiting Started 2023-04-11 20,284 enrolled NCT05757869
Phase 3 Terminated Started 2022-12-05 14,830 enrolled Results posted NCT05643573
Phase 3 Not yet recruiting Planned start 2022-09-01 1,300 planned NCT04981327
Phase 3 Terminated Started 2022-05-05 1,150 enrolled NCT05171049
Phase 3 Completed Started 2021-12-04 360 enrolled NCT05035277
Phase 3 Recruiting Started 2020-01-28 700 planned NCT03907046
Phase 3 Unknown status Started 2020-01-09 200 planned NCT04229264
Phase 3 Unknown status Started 2019-12-05 620 planned NCT03961334
Phase 3 Unknown status Started 2019-07-03 100 planned NCT04462003
Phase 3 Completed Started 2018-03-28 203 enrolled NCT03153150
Phase 3 Terminated Started 2018-01-19 1,015 enrolled Results posted NCT03192215
Phase 3 Completed Started 2017-07-14 370 enrolled Results posted NCT03080883
Phase 3 Completed Started 2017-06-20 108 enrolled NCT02933697
Phase 3 Terminated Started 2016-10-19 203 enrolled NCT02664155
Phase 3 Completed Started 2016-08-26 1,510 planned NCT02664649
Phase 3 Completed Started 2015-11-20 300 enrolled Results posted NCT02585713